Mr. Raymond C. Dabney, CEO of Cannabis Science says that their product is just a tiny bit of the whole capacity of Cannabis Science.
“The development of these two new pharmaceutical medicinal applications are just the tip of the iceberg for what we see as the future for Cannabis Science.
While we strive to increase our land capacity for growth and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy researching more potential needs for Cannabis related medical applications and developing the methods for delivery of these medications,” explained the CEO.
Over 10% of all Americans are affected by fibromyalgia, and many don’t even know they have it.
Neuropathic nerve pain is common in many people worldwide, and these patches can help in the treatment of both diseases. There’s a strong possibility that the patches even cure these health problems.
“As more states nationwide legislate for the legalization of cannabis and cannabis-derived medications, we here at Cannabis Science are focused on developing pharmaceutical formulations and applications to supply the huge growing demand expected over the coming few years,” finished Dabney.